20(S)-Protopanaxatriol (PPT) is a high-purity aglycone metabolite derived from ginsenosides, isolated from Panax ginseng roots. As a key reference standard, it enables advanced research in oncology, neuroprotection, and metabolic regulation. With ≥98% HPLC-verified purity and batch-specific CoA, this compound meets pharmacopeial requirements for drug development and quality control.